Artivion, Inc.

Ownership Transactions Reported by 24 Insiders

Symbol
AORT on NYSE
Industry
Surgical & Medical Instruments & Apparatus
Location
1655 Roberts Boulevard N W, Kennesaw, GA

Insiders trading volume in the past year

Artivion, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
James P. Mackin President & CEO $36.7M -$6.22M -14.5% Nov 13, 2025
John E. Davis Chief Commercial Officer $8.98M -$2.1M -18.9% Nov 14, 2025
Jean F. Holloway SVP, General Counsel $7.38M -$4.3M -36.8% Nov 14, 2025
David Ashley Lee Executive VP, COO & CFO $6.66M Mar 1, 2023
Amy Horton VP, Chief Accounting Officer $6.19M -$1.07M -14.7% Nov 17, 2025
Lance A. Berry Executive VP, CFO $3.81M -$211K -5.25% Mar 6, 2025
Daniel J. Bevevino Director $3.58M May 22, 2025
Thomas F. Ackerman Director $3.57M May 22, 2025
Jon W. Salveson Director $3.1M May 22, 2025
Ronald D. McCall Director $2.19M Aug 25, 2021
Marshall Stanton SVP, Clinical & MD Affair $2.03M -$5.61M -73.4% Nov 21, 2025
Harvey Morgan Director $1.75M Aug 30, 2021
Bullock James Director $1.64M May 22, 2025
Jeffrey H. Burbank Director $1.28M May 22, 2025
Elizabeth A. Hoff Director $1.23M -$189K -13.4% Nov 18, 2025
Marna Borgstrom Director $1.17M May 22, 2025
Anthony B. Semedo Director $1.12M -$20.9K -1.83% May 23, 2025
Andrew M. Green VP Regulatory $1.01M -$229K -18.5% Dec 4, 2024
Rochelle Maney VP, Quality $872K Mar 1, 2024
Matthew A. Getz VP, Human Resources $864K Aug 16, 2024
Dennis Maier SVP, Operations $625K Jun 6, 2023
Florian Tyrs VP, Global Operations $586K Feb 27, 2024
Franz Peter Barthold VP, Research & Development $585K Nov 8, 2022
Robert Thomson VP Research & Development $251K Feb 23, 2024

Recent Insider Transactions by Companies or Individuals for Artivion, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.